According to OPKO Health 's latest financial reports the company's total assets are $2.15 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $2.16 B | -9.68% |
2021-12-31 | $2.39 B | -2.97% |
2020-12-31 | $2.47 B | 7.09% |
2019-12-31 | $2.30 B | -5.79% |
2018-12-31 | $2.45 B | -5.36% |
2017-12-31 | $2.58 B | -6.38% |
2016-12-31 | $2.76 B | -1.18% |
2015-12-31 | $2.79 B | 120.84% |
2014-12-31 | $1.26 B | -8.9% |
2013-12-31 | $1.39 B | 380.11% |
2012-12-31 | $0.28 B | 26.29% |
2011-12-31 | $0.22 B | 194.8% |
2010-12-31 | $77.84 M | -10.96% |
2009-12-31 | $87.43 M | 301.72% |
2008-12-31 | $21.76 M | -45% |
2007-12-31 | $39.56 M | 352.1% |
2006-12-31 | $8.75 M | -2.76% |
2005-12-31 | $9 M | -10.63% |
2004-12-31 | $10.07 M | -11.21% |
2003-12-31 | $11.34 M | -35.24% |
2002-12-31 | $17.51 M | -36.6% |
2001-12-31 | $27.62 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $195.96 B | 8,977.26% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $73.79 B | 3,318.13% | ๐บ๐ธ USA |
![]() Regeneron Pharmaceuticals REGN | $30.65 B | 1,320.05% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $93.48 B | 4,230.40% | ๐บ๐ธ USA |
![]() LabCorp LH | $17.70 B | 720.13% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | $3.40 B | 57.60% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $43.09 B | 1,896.16% | ๐ฎ๐ฑ Israel |
![]() Ardelyx ARDX | $0.21 B | -90.22% | ๐บ๐ธ USA |